IRIS
ABBADESSA, GIANMARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 600
NA - Nord America 470
AS - Asia 150
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 469
IE - Irlanda 260
IT - Italia 132
SG - Singapore 88
DE - Germania 72
GB - Regno Unito 57
CN - Cina 40
FI - Finlandia 16
UA - Ucraina 12
GR - Grecia 11
BE - Belgio 8
IN - India 8
KR - Corea 7
SE - Svezia 7
CZ - Repubblica Ceca 6
FR - Francia 5
NL - Olanda 4
RU - Federazione Russa 4
MA - Marocco 3
AT - Austria 2
LB - Libano 2
AU - Australia 1
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
LU - Lussemburgo 1
MX - Messico 1
VN - Vietnam 1
Totale 1.226
Salva come PNG Salva come JPEG
Città #
Dublin 260
Singapore 69
Chandler 65
Santa Clara 60
Roxbury 33
Princeton 32
Cambridge 26
Munich 24
New York 24
Jacksonville 19
Bremen 18
Caserta 15
Ann Arbor 13
Medford 13
Boardman 12
Beijing 10
Helsinki 10
Milan 10
Naples 10
Brussels 8
Des Moines 7
Grafing 6
Lappeenranta 6
Pasadena 6
Brno 5
Redwood City 5
Rockville 5
Wilmington 5
Nanjing 4
Norwalk 4
Rome 4
Seoul 4
Aversa 3
Bari 3
Darmstadt 3
Hyderabad 3
Lviv 3
Meknes 3
Norwich 3
Pune 3
Athens 2
Atlanta 2
Columbus 2
Falconara Marittima 2
Groningen 2
Hebei 2
Houston 2
Jinan 2
Karlsruhe 2
Nanchang 2
Nutley 2
San Mateo 2
Sant'antimo 2
Volla 2
West Jordan 2
Amsterdam 1
Ashburn 1
Battipaglia 1
Berlin 1
Brdo 1
Cairo 1
Cangzhou 1
Cardiff 1
Catania 1
Changsha 1
Collegeville 1
Copenhagen 1
Elk Grove Village 1
Fairfield 1
Falkenstein 1
Ferrandina 1
Frankfurt am Main 1
Guangzhou 1
Hanover 1
Hong Kong 1
Jakarta 1
Lanzhou 1
Los Angeles 1
Lurago D'erba 1
Luxembourg 1
L’Aquila 1
Moscow 1
Napoli 1
New Haven 1
Nuremberg 1
Pognano 1
Quarto 1
Recanati 1
Secaucus 1
Shenyang 1
Sulmona 1
Suri 1
Taiyuan 1
Tokyo 1
Wenzhou 1
Woodbridge 1
Wuhan 1
Yoshkar-ola 1
Zanjan 1
Zhengzhou 1
Totale 891
Salva come PNG Salva come JPEG
Nome #
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 65
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 54
Telemedicine application to headache: a critical review 51
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 43
e-Health and multiple sclerosis: An update 42
Disability assessment using Google Maps 40
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 38
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 38
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 38
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 36
Social Media and Multiple Sclerosis in the Posttruth Age. 35
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 32
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 32
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 32
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 31
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis 31
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 29
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 28
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 28
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 26
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. 26
Public engagement and neurology: An update 26
Progressive multifocal leukoencephalopathy presenting with bilateral myoclonus: a case report 25
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis 25
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 25
Readability Analysis of Online Headache and Migraine Information 24
Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination 24
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab 23
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 22
Heidenhain variant of Creutzefeldt-Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities 21
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 21
How to manage with telemedicine people with neuromuscular diseases? 21
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 20
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 18
The Use of Social Media and Digital Devices Among Italian Neurologists 18
Digital therapeutics in neurology 18
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 17
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 17
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 16
Digital work engagement among Italian neurologists 16
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 14
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 13
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 13
Pain, quality of life, and religiosity in people with multiple sclerosis 11
Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? 9
DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France 8
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 8
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 8
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 8
Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology 7
Reply to Wostyn, P. Targeting the Cerebrospinal Fluid Compartment in Glaucoma: Still the Dark Side of the Moon? Comment on “Passaro et al. Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? J. Clin. Med. 2023, 12, 6900” 7
Targeting shared pathways in tauopathies and age-related macular degeneration: implications for novel therapies 7
Signs and symptoms of COVID‐19 in patients with multiple sclerosis 6
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression 6
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis 5
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 4
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 4
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 3
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 3
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 2
Totale 1.318
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.905
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 1 1 7 2 15 7 20 3
2020/202166 2 0 2 12 12 1 10 2 1 4 11 9
2021/2022232 2 15 4 4 57 15 2 3 17 5 22 86
2022/2023398 61 12 9 10 33 16 2 10 213 5 11 16
2023/2024293 16 11 21 13 77 39 13 5 7 4 11 76
2024/2025232 2 12 8 91 119 0 0 0 0 0 0 0
Totale 1.318